These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 21804527)
61. Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Ito Y; Miyauchi A Endocr J; 2009; 56(2):177-92. PubMed ID: 18703852 [TBL] [Abstract][Full Text] [Related]
62. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm. Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649 [TBL] [Abstract][Full Text] [Related]
63. Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management. Xu B; Ghossein R Eur J Surg Oncol; 2018 Mar; 44(3):338-347. PubMed ID: 28554832 [TBL] [Abstract][Full Text] [Related]
64. Significance of multifocality in papillary thyroid carcinoma. Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090 [TBL] [Abstract][Full Text] [Related]
65. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. Nikiforov YE; Seethala RR; Tallini G; Baloch ZW; Basolo F; Thompson LD; Barletta JA; Wenig BM; Al Ghuzlan A; Kakudo K; Giordano TJ; Alves VA; Khanafshar E; Asa SL; El-Naggar AK; Gooding WE; Hodak SP; Lloyd RV; Maytal G; Mete O; Nikiforova MN; Nosé V; Papotti M; Poller DN; Sadow PM; Tischler AS; Tuttle RM; Wall KB; LiVolsi VA; Randolph GW; Ghossein RA JAMA Oncol; 2016 Aug; 2(8):1023-9. PubMed ID: 27078145 [TBL] [Abstract][Full Text] [Related]
66. Unusual metastases from differentiated thyroid cancers: A multicenter study in Korea. Yoon JH; Jeon MJ; Kim M; Hong AR; Kim HK; Shin DY; Kim BH; Kim WB; Shong YK; Kang HC PLoS One; 2020; 15(8):e0238207. PubMed ID: 32841270 [TBL] [Abstract][Full Text] [Related]
70. Prognostic factors of clinical interest in poorly differentiated carcinomas of the thyroid. Volante M; Cavallo GP; Papotti M Endocr Pathol; 2004; 15(4):313-7. PubMed ID: 15681855 [TBL] [Abstract][Full Text] [Related]
71. Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma. Wong RM; Bresee C; Braunstein GD Thyroid; 2013 May; 23(5):566-74. PubMed ID: 23106409 [TBL] [Abstract][Full Text] [Related]
72. Follicular and Hurthle cell carcinomas of the thyroid: a comparative study. Evans HL; Vassilopoulou-Sellin R Am J Surg Pathol; 1998 Dec; 22(12):1512-20. PubMed ID: 9850177 [TBL] [Abstract][Full Text] [Related]
73. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations. Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855 [TBL] [Abstract][Full Text] [Related]